Search tips
Search criteria 


Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2010; 5(10): e13614.
Published online 2010 October 25. doi:  10.1371/journal.pone.0013614
PMCID: PMC2963611

miR-200b Precursor Can Ameliorate Renal Tubulointerstitial Fibrosis

Vineet Gupta, Editor


Members of the miR-200 family of micro RNAs (miRNAs) have been shown to inhibit epithelial-mesenchymal transition (EMT). EMT of tubular epithelial cells is the mechanism by which renal fibroblasts are generated. Here we show that miR-200 family members inhibit transforming growth factor-beta (TGF-beta)-induced EMT of tubular cells. Unilateral ureter obstruction (UUO) is a common model of EMT of tubular cells and subsequent tubulointerstitial fibrosis. In order to examine the role of miR-200 family members in tubulointerstitial fibrosis, their expression was investigated in the kidneys of UUO mice. The expression of miR-200 family miRNAs was increased in a time-dependent manner, with induction of miR-200b most pronounced. To clarify the effect of miR-200b on tubulointerstitial fibrosis, we injected miR-200b precursor intravenously. A single injection of 0.5 nM miR-200b precursor was sufficient to inhibit the increase of collagen types I, III and fibronectin in obstructed kidneys, and amelioration of fibrosis was confirmed by observation of the kidneys with Azan staining. miR-200 family members have been previously shown to inhibit EMT by reducing the expression of ZEB-1 and ZEB-2 which are known repressors of E-cadherin. We demonstrated that expression of ZEB-1 and ZEB-2 was increased after ureter obstruction and that administration of the miR-200b precursor reversed this effect. In summary, these results indicate that miR-200 family is up-regulated after ureter obstruction, miR-200b being strongly induced, and that miR-200b ameliorates tubulointerstitial fibrosis in obstructed kidneys. We suggest that members of the miR-200 family, and miR-200b specifically, might constitute novel therapeutic targets in kidney disease.


Micro RNAs are small non-coding RNA molecules that can regulate gene expression by interacting with multiple mRNAs and inducing either translational suppression or degradation of mRNA. Recently, several miRNAs have been implicated in regulating the initial step in epithelial-mesenchymal transition (EMT). Several reports have shown that members of the miR-200 family (miR-200a,b,c, miR-141 and miR-429) inhibit EMT through direct targeting of ZEB1 and ZEB2, which encode transcriptional repressors of E-cadherin in kidney tubular cells [1], breast cancer cells [2], and mammary epithelial cells [3]. Recent reports have indicated that a double-negative feedback loop between ZEB1, ZEB2 and miRNA-200 family members regulates EMT in kidney tubular cells [4].

In addition to being an early step in tumor metastasis, EMT is known to be associated with many pathophysiological situations, such as formation of various tissues during embryonic development [5], and of keratinocytes during wound healing [6]. In the kidneys, EMT of tubular epithelial cells is a mechanism by which renal fibroblasts are generated, and the importance of EMT has been demonstrated in experimental models, where blockade of EMT attenuates renal fibrosis. Renal fibrosis correlates with decline of renal function and is one of the causes of impaired renal function. The inhibition of EMT of tubular epithelial cells therefore represents a possible novel therapeutic approach to counteract the progression of renal disease [7], [8]. A common model of renal tubulointerstitial fibrosis is the mouse model of unilateral ureter obstruction (UUO) [9]. Given their ability to inhibit EMT, we investigated whether injection of miR-200 miRNA family precursors - chemically modified double strand of RNA which form RNA-induced silencing complex (RISC) like complex and can be processed by endonuclease Dicer into mature miR-200 family in cells - could ameliorate tubulointerstitial fibrosis by inhibition of EMT of tubular epithelial cells in UUO model mice.

Materials and Methods

Western blotting of E-cadherin and N-cadherin

Western blotting analysis of E-cadherin and N-cadherin was performed in HK-2 cells stimulated with 10 ng/ml transforming growth factor-beta (TGF-beta) for 24, 48 and 72 hours. To investigate the effect of micro RNAs on EMT, HK-2 cells were transfected with 20 pmol/ml miR-200 family precursors for 24 hours using Lipofectamine RNAiMax (Invitrogen), then stimulated with 10 ng/ml TGF-beta. After 24 hours the expression of E-cadherin and N-cadherin was investigated with western blotting. Western blotting analysis was performed following. Ten micro gram of protein extracts were separated on 10% SDS-polyacrylamide gels and transferred onto nylon membranes (Millipore Corp., Bedford, MA) using a semidry blotting system (Amersham Pharmacia Biotech, Uppsala, Sweden). After blocking in 1× PBS, 5% nonfat dry milk, 0.2% Tween 20 at 4 °C overnight, the membranes were incubated with the primary antibodies in blocking buffer (1× PBS, 2% nonfat dry milk, 0.2% Tween 20) for 1 h at room temperature. Antibodies were used at a dilution of 1[ratio]300. The membranes were washed three times with the blocking buffer and then incubated with secondary antibodies, which were conjugated with horseradish peroxidase (Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom) at a final dilution of 1[ratio]7,000. After final washes with 1× PBS, 0.2% Tween 20, the signals were detected using ECL chemiluminescence reagents (Amersham Pharmacia Biotech). Antibodies; E-cadherin, mouse monoclonal antibody anti-E-cadherin (BD Bioscience), N-cadherin, mouse monoclonal antibody anti-N-cadherin (BD Bioscience). To confirm that the same amount of protein was investigated, the expression of beta-actin was investigated simultaneously. All experiments were performed in triplicate.

Micro RNA assays

Total RNA was extracted using the miRVana miRNA isolation kit (Ambion). For micro RNA assays, mature miRNAs were reverse transcribed using a specific adapter, and real-time PCR was performed TaqMan micro RNA assays (Applied Biosystems). All data were normalized to U6 expression.

Injection of miR-200b precursor

All procedure used in this study were approved by the Ethics Committee for the Use of Experimental Animals in Tokyo University. All possible efforts were made to minimize animal suffering and the numbers of animal used. The renal press-mediated transfection method was used to efficiently deliver the miR-200b precursor to the kidney [10]. 7 week old Balbc mice were intravenously injected with 0.5 nM miR-200b precursor (Ambion), immediately followed by pressing the left kidney. As a control experiment, 0.5 nM negative control micro RNA precursor (Ambion) and Cy3 dye-labeled Pre-miR control (Ambion) were intravenously administered as above.

Semiquantitative Evalutation of fibrosis

To investigate fibrosis in the UUO model mice, the kidneys were harvested and fixed with 4% paraformaldehyde. 3microm paraffin section was stained with Azan stating. The slides were coded and examined in a blind fashion. Each kidney specimen were graded according to the extent of fibrosis by using the method previously described [11]. Grades were assigned to each slide according to the following criteria. Grade of fibrosis: 0, no fibrosis; 1, mild fibrosis (10 to 30% in area); 2, moderate fibrosis (30% to 50% in area); 3, severe fibrosis (>50% in area).

Real-time PCR of type I, III collagen, fibronectin, E-cadherin, ZEB-1 and ZEB-2

Real-time PCR was performed to measure the expression of type I,III collagen, fibronectin, ZEB-1, ZEB-2 and E-cadherin of UUO day-6 kidneys. The data are normalized to beta-actin mRNA and shown as mean±S.E.(n = 8).Real-time PCR was performed with following PCR primers: type I collagen, 5′-TCCTGGCAACAAAGGAGACA-3′ and 5′-GGGCTCCTGGTTTTCCTTCT-3′; type III collagen, 5′-ACGTAGATGAAxTTGGGATGCAG-3′ and 5′-GGGTTGGGGCAGTCTAGTC-3′; Fibronectin, 5′-AGACCATACCTGCCGAATGTAG-3′ and 5′-GAGAGCTTCCTGTCCTGTAGAG-3′; E-cadheirn, 5′-GCACTCTTCTCCTGGTCCTG-3′ and 5′-TATGAGGCTGTGGGTTCCTC; ZEB1, 5′-TGGCAAGACAACGTGAAAGA-3′ and 5′-AACTGGGAAAATGCATCTGG-3′; ZEB2, 5′-TAGCCGGTCCAGAAGAAATG-3 and 5′-GGCCATCTCTTTCCTCCAGT-3′.

Immunofluorescence studies

To detect the change of the expression of vimentin and cytokeratin 18 in the kidneys of UUO by miR-200b precursor, we examined the localization of them with immunofluorescein staining. The paraffin sections of kidneys were incubated with rabbit monoclonal antibody anti-vimentin (EPOT MICS) or mouse monoclonal anti-cytokeratin 18 (PROGEN) for 1 hr. The sections were washed with PBS and incubated with the FITC-conjugated anti-rabbit IgG antibody (DAKO cytomation) (1[ratio]50) or the Hilyte Fluor 555-labeled anti-mouse IgG antibody (Ana Spec, Inc.) (1[ratio]50) for 30 min, washed with PBS and observed under the Confocal Scanner Unit.

ZEB1 and ZEB2 3′-UTR Luciferase Reporter Assays

The 3′-UTRs for both ZEB1 and ZEB2 were PCR-amplified from genomic DNA. PCR primers used to amplify the Zeb1 3′-UTR include 5′-AAAAATCCGGGTGTGCCTGA-3′ (forward) and 5′-AACTGCTTTCTACTGCTCTG-3′ (reverse), whereas the primers used to amplify the Zeb-2 3′-UTR include 5′-CAGTTCAGCCAAGACAGAGT-3′ (forward) and 5′-TTCGAGCATGGTCATTTTC-3′UTR (reverse). Amplified 3′-UTRs were cloned downstream of the luciferase coding region in the pGL-3 control (Clontech). HK-2 cells were seeded in 6-well plates 24 hr prior to transfection. 2.5microg of reporter plasmid along with 2.5 microg of control Renilla-luciferase plasmid were co-transfected using Lipofectamine LTX(Invitrogen). To assess the effect of miR-200 family precursor on reporter activity, 50 pM of synthetic precursor miRNAs (pre-miRs) (Ambion) were co-transfected. All experiments were performed in triplicate.

Statistical Analysis

All data are reported as mean ± S.E. When comparisons were made between two different groups, statistical significance was determined by the Student's t-test using the Stat View software program.


Initial western blotting analysis demonstrated TGF-beta-mediated repression of E-cadherin, and induction of N-cadherin, in HK-2 kidney tubular cells (Fig. 1a). All miR-200 family precursors tested were capable of inhibiting the reduction of E-cadherin and up-regulation of N-cadherin affected by TGF-beta in HK-2 cells (Fig. 1b, c).

Figure 1
miR-200 family members can ameliorate EMT and tubulointerstitial fibrosis in UUO model mouse kidneys.

We next investigated the role of miR-200 family members in EMT of tubular cells in UUO mice. Micro RNA assays showed that expression of all members of the miR-200 family tested were increased in a time-dependent manner after ureter obstruction (Fig. 1d); the induction of miR-200b was most pronounced. Since the most efficient in vitro inhibition of TGF-beta was mediated by the miR200-b miRNA (Fig. 1b and Fig. 1c) we next evaluated its effect in vivo by injecting miR-200b precursor via the abdominal vein prior to occlusion of the left ureter. A single injection of 0.5 nM miR-200b precursor was sufficient to ameliorate tubulointerstitial fibrosis in the kidney 6 days after UUO (Fig. 1e), an observation confirmed by real time PCR analysis of type I collagen, type III collagen and fibronectin and Azan staining (Fig. 1e). To demonstrate that reduction of ZEB1 and ZEB2 levels reduces epithelial to mesenchymal transition, tissue stains for epithelial makers, cytokeratin 18 and for mesenchymal markers, vimentin in animals treated with miR-200b and control animals have shown in Figure 1f.

Laser microscopic observation revealed that injected Cy3 dye-labeled Pre-miR control could be observed in tubular cells (Fig. 2a). Micro RNA assays revealed that injected miR-200b precursor can be converted to mature miR-200b in mouse kidneys (Fig. 2b)

Figure 2
Injected miR-200b precursor can be converted to mature miR-200b in kidneys.

Previous studies showed that inhibition of EMT by miR-200 family members was mediated by their inhibition of the expression of the E-cadherin repressors ZEB1 and ZEB2 through binding to the 3′-UTR region of ZEB1 and ZEB2 mRNAs [1][3]. In order to confirm that miR-200 family members target ZEB1 and ZEB2 3′-UTRs, we co-transfected either ZEB1-3′UTR-luciferase or ZEB2-3′UTR-luciferase reporter vectors with miR-200 family precursors in HK-2 cells. The luciferase activity of both reporters was significantly reduced in the presence of all miR-200 family members tested (Fig. 3).

Figure 3
miR-200 family members target the transcriptional repressors ZEB1 and ZEB2.

We next investigated whether expression of ZEB1 and ZEB2 increased as a result of kidney obstruction. Real time PCR analysis confirmed that ZEB1 and ZEB2 were induced in a time-dependent manner after obstruction (Fig. 4a, b), an effect reversed by injection of miR-200b precursor (Fig. 4c). These results indicate that members of the miR-200 family of miRNAs are induced after ureter obstruction and that miR-200b ameliorates tubulointerstitial fibrosis in obstructed kidneys.

Figure 4
ZEB1 and ZEB2 expression in UUO model mice.


In this report, we show that members of the miR-200 family of miRNAs are induced after ureter obstruction and that miR-200b ameliorates tubulointerstitial fibrosis in obstructed kidneys via inhibition of EMT of tubular cells.

Recent reports indicate that a cluster of key microRNAs are highly expressed in kidneys [12] and that there are differences in the micro RNA expression profile in renal cortex versus medulla [13]; however, it was not until recently that specific roles of micro RNAs in renal function were investigated. These studies revealed that key micro RNAs can play roles in TGF-beta1 actions [14] and diabetic kidney disease [15] and that podocyte-specific deletion of Dicer, a key enzyme involved in micro RNA biogenesis, led to progressive glomerular and tubular damage along with proteinuria and other podocyte defects in mice [16].

Kato et al. demonstrated that the expression miR-192 is increased in renal glomeruli obtained from mouse models of type 1 and type 2 diabetes relative to corresponding control mice [14]. They also showed that the expression of miR-192 was increased by TGF-beta in mouse mesangial cells (MCs), whereas, conversely, the expression of its target, Zeb2, was decreased. This also paralleled in increased Collagen 1-alpha 2 (Col 1a2) and TGF-beta expression. These results suggested that the increase in TGF-beta in vivo in diabetic glomeruli and in vitro in MCs could induce miR-192 expression, which could target and down-regulate Zeb2 thereby to increase Col 1a2.

Several articles have shown that the miR-200 family targets ZEB1 and ZEB2 [1][4]. We also observed that Zeb1 and Zeb2 was a target of miR-200 family members that tended to be up-regulated by TGF-beta in kidney tubular cell lines. Thus, TGF-beta-induced increase in the expression of microRNAs (miR-192 and miR-200 family members) might coordinately down-regulate E-box repressors Zeb1 and Zeb2 to inhibit EMT and fibrosis of kidneys. Conversely, the down-regulation of ZEB1 and ZEB2 by TGF-beta via miR-200 family and miR-192 can affect upstream E-box regions [14].

Conversely, there are several reports that miR-200 family members and miR-192 can be down-regulated by TGF-beta, and this promotes EMT in cancer and other cell lines via subsequent up-regulation of targets ZEB1 and ZEB2 to repress E-cadherin [1][4]. Thus the effects of renal microRNAs may be cell type specific, and the microRNA signaling networks that mediate the effects of TGF-beta on MCs and epithelial cells and on metastatic and fibrotic EMT may not be identical.

Tubulointerstitial fibrosis is a common pathological event in the kidney during progressive renal injury and previous reports have shown that inhibition of tubulointerstitial fibrosis has a beneficial effect on kidney function [17][19]. We suggest that members of the miR-200 family, and miR-200b specifically, might constitute novel therapeutic targets in various kidney diseases.

Previous studies have shown that, in addition to TGF-beta, renal tubulointerstitial fibrosis can be induced by toll like receptor [18] and connective tissue growth factor [20] and that this effect can be opposed angiotensin II receptor blockers [21], statins [22], PPAR gamma agonists [23] and vitamin D [24]. We suggest that the therapeutic role of miR-200 family members be investigated in other models of kidney disease, particularly in the context of these factors. Finally, an alternative therapeutic approach in kidney disease may be to identify compounds that increase the expression levels of members of the miR-200 family of microRNAs.


This study indicates that miR-200 family is up-regulated after ureter obstruction, miR-200b being strongly induced, and that miR-200b ameliorates tubulointerstitial fibrosis in obstructed kidneys.


Competing Interests: The authors have declared that no competing interests exist.

Funding: The authors have no support or funding to report.


1. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1and SIP1. Nature cell biology. 2008;10:593–601. [PubMed]
2. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008;9:582–589. [PMC free article] [PubMed]
3. Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008;283:14910–14914. [PMC free article] [PubMed]
4. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008;68:7846–7854. [PubMed]
5. Duband JL, Monier F, Delannet M, Newgreen D. Epithelial-mesenchymal transition during neural crest development. Acta Anat. 1995;154:63–78. [PubMed]
6. Thiery JP. Epithelial-mesenchymal transition in development and pathologies. Curr Opin Cell Biol. 2003;15:740–746. [PubMed]
7. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis. 1992;20:1–17. [PubMed]
8. Müller GA, Markovic-Lipkovski J, Frank J, Rodemann HP. The role of interstitial cells in progression of renal diseases. J Am Soc Nephrol. 1992;10(Suppl):S198–205. [PubMed]
9. Sharma AK, Mauer SM, Kim Y, Micheal AF. Interstitial fibrosis in obstructive nephropathy. Kidney Int. 1993;44:774–788. [PubMed]
10. Mukai H, Kawakami S, Hashida M. Renal press-mediated transfection method for plasmid DNA and siRNA to the kidney. Biochem Biophys Res Commun. 2008;372:383–387. [PubMed]
11. Oba S, Kimura K, Suzuki N, Mise N, Tojo A, et al. Relevance of periglomerular myofibroblasts in progression of human glomerulonephritis. Am J Kidney Dis. 1998;324:19–25. [PubMed]
12. Sun Y, Koo S, White N, Peralta E, Esau C, et al. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. 2004;32:e188. [PMC free article] [PubMed]
13. Tian Z, Greene AS, Pietrusz JL, Matus IR, Liang M. MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res. 2008;18:404–411. [PubMed]
14. Kato M, Zhang J, Wang M, LantingL, Yuan H, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA. 2007;104:3432–3437. [PubMed]
15. Wang Q, Wang Y, Minto AW, Wang J, Shi Q, et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 2008;22:4126–4135. [PubMed]
16. Harvey SJ, Jarad G, Cunningham J, Goldberg S, Schermer B et al. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J Am Soc Nephrol. 2008;19:2150–2158. [PubMed]
17. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 2002;110:341–350. [PMC free article] [PubMed]
18. Leemans JC, Butter LM, Pulskens WP, Teske GJ, Claessen N, et al. The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS ONE. 2009;4:e5704. [PMC free article] [PubMed]
19. Vitalone MJ, O'Connell PJ, Jimenez-Vera E, Yuksel A, Wavamunno M, et al. Epithelial-to-mesenchymal transition in early transplant tubulointerstitial damage. J Am Soc Nephrol. 2008;19:1571–1583. [PubMed]
20. Yokoi H, Mukoyama M, Sugawara A, Mori K, Nagae T, et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol. 2002;282:F933–942. [PubMed]
21. Klahr S, Ishidoya S, Morrissey J. Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis. 1995;16:141–146. [PubMed]
22. Vieira JM, Jr, Mantovani E, Rodrihues LT, Dellê H, Noronha IL, et al. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Neprol Dial Transplant. 2005;20:1582–1591. [PubMed]
23. Kawai T, Masaki T, Doi S, Arakawa T, Yokoyama Y, et al. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Invest. 2009;89:47–58. [PubMed]
24. Tan X, Liu Y. Therapeutic role and potential mechanisms of active vitamin D in renal interstitial fibrosis. J Steriod Biochem Mol Biol. 2007;103:491–496. [PMC free article] [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science